322 related articles for article (PubMed ID: 31964401)
1. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
3. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
4. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
5. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Chenet SM; Oyarce A; Fernandez J; Tapia-Limonchi R; Weitzel T; Tejedo JR; Udhayakumar V; Jercic MI; Lucchi NW
Am J Trop Med Hyg; 2021 Mar; 104(5):1811-1813. PubMed ID: 33782210
[TBL] [Abstract][Full Text] [Related]
8. Selection of Cytochrome
Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
[TBL] [Abstract][Full Text] [Related]
9. Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.
Eshetu T; Berens-Riha N; Fekadu S; Tadesse Z; Gürkov R; Hölscher M; Löscher T; Miranda IB
Malar J; 2010 Aug; 9():226. PubMed ID: 20691106
[TBL] [Abstract][Full Text] [Related]
10. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
12. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Schwöbel B; Alifrangis M; Salanti A; Jelinek T
Malar J; 2003 Mar; 2():5. PubMed ID: 12665429
[TBL] [Abstract][Full Text] [Related]
13. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
14. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
[TBL] [Abstract][Full Text] [Related]
15. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
[TBL] [Abstract][Full Text] [Related]
17. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G
Malar J; 2002 Feb; 1():1. PubMed ID: 12057021
[TBL] [Abstract][Full Text] [Related]
18. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
[TBL] [Abstract][Full Text] [Related]
20. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]